<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2019-23-1-60-66</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1666</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. CLINICAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>ДИСФУНКЦИЯ ЩИТОВИДНОЙ ЖЕЛЕЗЫ ПРИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК</article-title><trans-title-group xml:lang="en"><trans-title>THYROID DYSFUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волкова</surname><given-names>A. P.</given-names></name><name name-style="western" xml:lang="en"><surname>Volkova</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Проф. Волкова Анна Ральфовна</p><p>197022, Санкт-Петербург, ул. Л. Толстого, д. 6–8, корп. 11. </p><p>Тел.: +7921-334-29-63 </p></bio><bio xml:lang="en"><p>Prof. Anna R. Volkova MD, PhD, DMedSci</p><p>197022, St-Petersburg, L. Tolstoy st., 6-8, build. 11. </p><p>Phone: +79213342963 </p></bio><email xlink:type="simple">volkovaa@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дыгун</surname><given-names>O. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Dygun</surname><given-names>O. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дыгун Ольга Дмитриевна - ассистент</p><p>197022, Санкт-Петербург, ул. Л. Толстого, д. 6–8, корп. 11. </p><p>Тел.: +7965-797-11-79 </p></bio><bio xml:lang="en"><p>Ass. Olga D. Dygun MD</p><p>197022, St-Petersburg, L. Tolstoy st., 6-8, build. 11. </p><p>Phone: +79657971179 </p></bio><email xlink:type="simple">dod.90@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абрамова</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Abramova</surname><given-names>I. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Абрамова Инна Михайловна - клинический ординатор</p><p>197022, Санкт-Петербург, ул. Л. Толстого, д. 6–8, корп. 11.  </p><p>Тел.: +7950-006-29-40 </p></bio><bio xml:lang="en"><p>Inna M. Abramova - resident</p><p>197022, St-Petersburg, L. Tolstoy st., 6-8, build. 11.  </p><p>Phone: +79500062940 </p></bio><email xlink:type="simple">vortexgin7@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нечаева</surname><given-names>E. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nechaeva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нечаева Евгения Владимировна - студентка VI курса</p><p>197022, Санкт-Петербург, ул. Л. Толстого, д. 6–8.</p><p>Тел.: +7931-583-73-13 </p></bio><bio xml:lang="en"><p>Evgenia V. Nechaeva - student</p><p>197022, St-Petersburg, L. Tolstoy st., 6-8, build. 11. </p><p>Phone: +79315837313 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галкина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Galkina</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галкина Ольга Владимировна, канд. мед. наук, заведующая</p><p>197022, Санкт-Петербург, ул. Л. Толстого, д. 17, корп. 54. </p><p>Тел.: +7921-385-52-86 </p></bio><bio xml:lang="en"><p>Olga V. Galkina MD, PhD</p><p>197022, Russia, St-Petersburg, L. Tolstoy st., 17, build. 54. </p><p>Phone: +79213855286 </p></bio><email xlink:type="simple">ovgalkina@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белякова</surname><given-names>Л. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Belyakova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Белякова Людмила Анатольевна - старший научный сотрудник</p><p>197022, Санкт-Петербург, ул. Л. Толстого, д. 6–8.</p><p>Тел.: +7906-264-92-57 </p></bio><bio xml:lang="en"><p>Lyudmila A. Belyakova - Senior Researcher</p><p>197022, Russia, St-Petersburg, L. Tolstoy st., 6-8.</p><p>Phone: +79062649257 </p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Кафедра терапии факультетской с курсом эндокринологии, кардиологии и функциональной диагностики с клиникой Первого Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>The Faculty therapy department, First Pavlov St.-Petersburg State Medical University, St.-Petersburg</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Лаборатория биохимического гомеостаза Научно-исследовательского института нефрологии Первого Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Laboratory of biochemical homeostasis of the Scientific Research Institute of Nephrology, First Pavlov St.-Petersburg State Medical University, St.-Petersburg</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>отдел фармакоэпидемиологии и биомедицинской статистики Первого Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Department of Pharmacoepidemiology and Biomedical Statistics, First Pavlov St.-Petersburg State Medical University, St.-Petersburg</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>06</day><month>02</month><year>2019</year></pub-date><volume>23</volume><issue>1</issue><fpage>60</fpage><lpage>66</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Волкова A.P., Дыгун O.Д., Абрамова И.М., Нечаева E.В., Галкина О.В., Белякова Л.A., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Волкова A.P., Дыгун O.Д., Абрамова И.М., Нечаева E.В., Галкина О.В., Белякова Л.A.</copyright-holder><copyright-holder xml:lang="en">Volkova A.R., Dygun O.D., Abramova I.M., Nechaeva E.V., Galkina O.V., Belyakova L.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1666">https://journal.nephrolog.ru/jour/article/view/1666</self-uri><abstract><p>Известно, что у пациентов с хронической болезнью почек (ХБП) часто отмечаются гипотиреоз, а также нарушение выведение йода с мочой. Высокое содержание йода в щитовидной железе и тканях приводит к нарушению синтеза и периферического метаболизма тиреоидных гормонов. В условиях гипотиреоза происходит нарушение реабсорбции натрия и воды в проксимальном канальце, увеличивается объем фильтрата. ЦЕЛЬ: изучить встречаемость гипотиреоза в условиях стационара у пациентов с различными стадиями ХБП. ПАЦИЕНТЫ И МЕТОДЫ. Обследовано 953 больных клиник ПСПбГМУ (группа скрининга). Всем проводили определение ТТГ, Т4 св., сывороточного креатинина и рассчитывали СКФ по формуле CKD-EPI. Группу больных гипотиреозом составили 466 пациентов. РЕЗУЛЬТАТЫ. СКФ в группе скрининга и группе больных гипотиреозом коррелировала с возрастом. Гипотиреоз был ассоциирован с женским полом и старшим возрастом. В группе больных с продвинутой стадией ХБП (3Б-5) частота выявления субклинического и манифестного гипотиреоза была в 3 раза выше, чем в группе больных с нормальной СКФ (р=0,007). В группе больных гипотиреозом частота продвинутых стадий ХБП (3Б-5) была в 2 раза выше, чем в группе сравнения (р=0,02). У больных с ХБП была выявлена прямая корреляционная связь между СКФ и Т3 св. (r=0,34, р=0,02). Антитела к тиреопероксидазе были выявлены у 64 % больных с ХБП с гипотиреозом. ЗАКЛЮЧЕНИЕ. Для больных с ХБП характерно наличие синдрома эутиреоидной патологии (синдром «низкого Т3»). Гипотиреоз у больных с ХБП не всегда является исходом аутоиммунного тиреоидита.</p></abstract><trans-abstract xml:lang="en"><p>It is known that patients with chronic kidney disease (CKD) often have hypothyroidism. In patients with CKD, iodine excretion in the urine is disrupted. The high content of iodine in the thyroid gland and tissues leads to a disruption in the synthesis and peripheral metabolism of thyroid hormones. In hypothyroidism, there is a disruption of sodium and water reabsorption in the proximal tubule, the volume of the filtrate increases, the volume of the tubular apparatus overloads, and the eGFR decreases. THЕ AIM: to study the occurrence of hypothyroidism in patients with different stages of CKD, to evaluate the parameters of thyroid status and antithyroid antibodies in patients with CKD. PATIENTS AND METHODS. 953 patients from I.P. Pavlov SPbSMU clinics (screening group) were examined. TSH, free T4, serum creatinine were defined and eGFR was calculated using the formula CKD-EPI in all patients. A group of patients with hypothyroidism accounted for 466 patients. Patients with a normal TSH of 0.4-2.5 mIU / L (comparison group) were selected from the screening group. RESULTS. eGFR in the screening group and in the group of hypothyroid patients correlated with age. Hypothyroidism was associated with female sex and older age. In the group of patients with advanced stage CKD (3B-5), the incidence of subclinical and manifest hypothyroidism was 3 times higher than in the group with normal GFR (GFR&gt; 90 ml / min, p = 0.007). In the group of patients with hypothyroidism, the frequency of advanced stages of CKD (3B-5) was 2 times higher than in the comparison group (p = 0.02). In patients with CKD, a direct correlation was found between GFR and free T3 (r = 0.34, p = 0.02). Thyroid peroxidase antibodies were revealed in 64% of patients with CKD with hypothyroidism. CONCLUSION. Hypothyroidism is associated with chronic kidney disease. For patients with CKD, there is a syndrome of euthyroid pathology ("low T3" syndrome). Hypothyroidism in patients with CKD is not always the outcome of autoimmune thyroiditis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гипотиреоз</kwd><kwd>хроническая болезнь почек</kwd><kwd>тиреотропный гормон гипофиза</kwd><kwd>скорость клубочковой фильтрации</kwd><kwd>синдром «низкого Т3»</kwd><kwd>антитела к тиреопероксидазе</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypothyroidism</kwd><kwd>chronic kidney disease</kwd><kwd>thyroid-stimulating hormone</kwd><kwd>estimated glomerular filtration rate</kwd><kwd>"low T3" syndrome</kwd><kwd>thyroid peroxidase antibody</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Rhee CM, Kalantar-Zadeh K, Streja E et al. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease. Nephrol Dial Transplant 2015; 30: 282–287. Doi: 10.1093/ndt/gfu303</mixed-citation><mixed-citation xml:lang="en">Rhee CM, Kalantar-Zadeh K, Streja E et al. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease. Nephrol Dial Transplant 2015; 30: 282–287. Doi: 10.1093/ndt/gfu303</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chuang M-H, Liao K-M, Hung Y-M et al. Abnormal ThyroidStimulating Hormone and Chronic Kidney Disease in Elderly Adults in Taipei City. J Am Geriatr Soc 2016; 64: 1267–1273. Doi: 10.1111/jgs.14102</mixed-citation><mixed-citation xml:lang="en">Chuang M-H, Liao K-M, Hung Y-M et al. Abnormal ThyroidStimulating Hormone and Chronic Kidney Disease in Elderly Adults in Taipei City. J Am Geriatr Soc 2016; 64: 1267–1273. Doi: 10.1111/jgs.14102</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lee DY, Jee JH, Jun JE et al. The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects. Endocrine 2017; 55: 503–512. Doi: 10.1007/s12020-016-1138-8</mixed-citation><mixed-citation xml:lang="en">Lee DY, Jee JH, Jun JE et al. The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects. Endocrine 2017; 55: 503–512. Doi: 10.1007/s12020-016-1138-8</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chandra A. Prevalence of hypothyroidism in patients with chronic kidney disease: a cross-sectional study from North India. Kidney Res Clin Pract 2016; 35: 165–168. Doi: 10.1016/j.krcp.2016.06.003</mixed-citation><mixed-citation xml:lang="en">Chandra A. Prevalence of hypothyroidism in patients with chronic kidney disease: a cross-sectional study from North India. Kidney Res Clin Pract 2016; 35: 165–168. Doi: 10.1016/j.krcp.2016.06.003</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Chonchol M, Lippi G, Salvagno G et al. Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1296–1300. Doi: 10.2215/CJN.00800208</mixed-citation><mixed-citation xml:lang="en">Chonchol M, Lippi G, Salvagno G et al. Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1296–1300. Doi: 10.2215/CJN.00800208</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lo JC, Chertow GM, Go AS et al. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 2005; 67: 1047–1052. Doi: 10.1111/j.1523-1755.2005.00169.x</mixed-citation><mixed-citation xml:lang="en">Lo JC, Chertow GM, Go AS et al. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 2005; 67: 1047–1052. Doi: 10.1111/j.1523-1755.2005.00169.x</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Schultheiss UT, Daya N, Grams ME et al. Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study. Nephrol Dial Transplant 2017; 32: 1874–1881. Doi: 10.1093/ndt/gfw301</mixed-citation><mixed-citation xml:lang="en">Schultheiss UT, Daya N, Grams ME et al. Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study. Nephrol Dial Transplant 2017; 32: 1874–1881. Doi: 10.1093/ndt/gfw301</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rhee CM, Ravel VA, Streja E et al. Thyroid Functional Disease and Mortality in a National Peritoneal Dialysis Cohort. J Clin Endocrinol Metab 2016; 101: 4054–4061. Doi: 10.1210/ jc.2016-1691</mixed-citation><mixed-citation xml:lang="en">Rhee CM, Ravel VA, Streja E et al. Thyroid Functional Disease and Mortality in a National Peritoneal Dialysis Cohort. J Clin Endocrinol Metab 2016; 101: 4054–4061. Doi: 10.1210/ jc.2016-1691</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gardner DF, Mars DR, Thomas RG et al. Iodine retention and thyroid dysfunction in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1986; 7: 471–476</mixed-citation><mixed-citation xml:lang="en">Gardner DF, Mars DR, Thomas RG et al. Iodine retention and thyroid dysfunction in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1986; 7: 471–476</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sato K, Okamura K, Yoshinari M et al. Reversible primary hypothyroidism and elevated serum iodine level in patients with renal dysfunction. Acta Endocrinol (Copenh) 1992; 126: 253–259</mixed-citation><mixed-citation xml:lang="en">Sato K, Okamura K, Yoshinari M et al. Reversible primary hypothyroidism and elevated serum iodine level in patients with renal dysfunction. Acta Endocrinol (Copenh) 1992; 126: 253–259</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Кеттайл ВМ, Арки РА. Патофизиология эндокринной системы. BINOM Publishers 2001 [Kettai`l VM, Arki RA. Patofiziologiia e`ndokrinnoi` sistemy`. BINOM Publishers 2001]</mixed-citation><mixed-citation xml:lang="en">Кеттайл ВМ, Арки РА. Патофизиология эндокринной системы. BINOM Publishers 2001 [Kettai`l VM, Arki RA. Patofiziologiia e`ndokrinnoi` sistemy`. BINOM Publishers 2001]</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lim VS, Fang VS, Katz AI et al. Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest 1977; 60: 522–534. Doi:10.1172/JCI108804</mixed-citation><mixed-citation xml:lang="en">Lim VS, Fang VS, Katz AI et al. Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest 1977; 60: 522–534. Doi:10.1172/JCI108804</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the ‘euthyroid sick syndrome’. Endocr Rev 1982; 3: 164–217. Doi: 10.1210/edrv-3-2-164</mixed-citation><mixed-citation xml:lang="en">Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the ‘euthyroid sick syndrome’. Endocr Rev 1982; 3: 164–217. Doi: 10.1210/edrv-3-2-164</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Barlet C, Doucet A. Lack of stimulation of kidney Na-KATPase by thyroid hormones in long-term thyroidectomized rabbits. Pflugers Arch 1986; 407: 428–431</mixed-citation><mixed-citation xml:lang="en">Barlet C, Doucet A. Lack of stimulation of kidney Na-KATPase by thyroid hormones in long-term thyroidectomized rabbits. Pflugers Arch 1986; 407: 428–431</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Suher M, Koc E, Ata N et al. Relation of thyroid disfunction, thyroid autoantibodies, and renal function. Ren Fail 2005; 27: 739–742</mixed-citation><mixed-citation xml:lang="en">Suher M, Koc E, Ata N et al. Relation of thyroid disfunction, thyroid autoantibodies, and renal function. Ren Fail 2005; 27: 739–742</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Michael UF, Barenberg RL, Chavez R et al. Renal handling of sodium and water in the hypothyroid rat. Clearance and micropuncture studies. J Clin Invest 1972; 51: 1405–1412. Doi: 10.1172/JCI106936</mixed-citation><mixed-citation xml:lang="en">Michael UF, Barenberg RL, Chavez R et al. Renal handling of sodium and water in the hypothyroid rat. Clearance and micropuncture studies. J Clin Invest 1972; 51: 1405–1412. Doi: 10.1172/JCI106936</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hanna FW, Scanlon MF. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet (London, England) 1997; 350: 755–756. Doi: 10.1016/S0140-6736(05)62563-9</mixed-citation><mixed-citation xml:lang="en">Hanna FW, Scanlon MF. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet (London, England) 1997; 350: 755–756. Doi: 10.1016/S0140-6736(05)62563-9</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов АВ, Шилов ЕМ, Добронравов ВА и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Клиническая нефрология 2012; 4: 4–26 [Smirnov AV, Shilov EM, Dobronravov VA et al. Natcional`ny`e rekomendatcii. Khronicheskaia bolezn` pochek: osnovny`e printcipy` skrininga, diagnostiki, profilaktiki i podhody` k lecheniiu. Clinicheskaia nefrologiia 2012; 4: 4–26]</mixed-citation><mixed-citation xml:lang="en">Смирнов АВ, Шилов ЕМ, Добронравов ВА и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Клиническая нефрология 2012; 4: 4–26 [Smirnov AV, Shilov EM, Dobronravov VA et al. Natcional`ny`e rekomendatcii. Khronicheskaia bolezn` pochek: osnovny`e printcipy` skrininga, diagnostiki, profilaktiki i podhody` k lecheniiu. Clinicheskaia nefrologiia 2012; 4: 4–26]</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Фадеев ВВ. По материалам клинических рекомендаций Американской ассоциации клинических эндокринологов и Американской тиреоидной ассоциации по диагностике и лечению гипотиреоза у взрослых. Клиническая и экспериментальная тиреоидология 2012; 8: 9–16. Doi: 10.4158/EP12280. GL [Fadeev VV. Po materialam clinicheskikh rekomendatcii` Amerikanskoi` assotciatcii clinicheskikh e`ndokrinologov i Amerikanskoi` tireoidnoi` assotciatcii po diagnostike i lecheniiu gipotireoza u vzrosly`kh. Clinicheskaia i e`ks perimental`naia tireoidologiia 2012; 8: 9–16. Doi: 10.4158/EP12280.GL]</mixed-citation><mixed-citation xml:lang="en">Фадеев ВВ. По материалам клинических рекомендаций Американской ассоциации клинических эндокринологов и Американской тиреоидной ассоциации по диагностике и лечению гипотиреоза у взрослых. Клиническая и экспериментальная тиреоидология 2012; 8: 9–16. Doi: 10.4158/EP12280. GL [Fadeev VV. Po materialam clinicheskikh rekomendatcii` Amerikanskoi` assotciatcii clinicheskikh e`ndokrinologov i Amerikanskoi` tireoidnoi` assotciatcii po diagnostike i lecheniiu gipotireoza u vzrosly`kh. Clinicheskaia i e`ks perimental`naia tireoidologiia 2012; 8: 9–16. Doi: 10.4158/EP12280.GL]</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Vanderpump MP, Tunbridge WM, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55–68</mixed-citation><mixed-citation xml:lang="en">Vanderpump MP, Tunbridge WM, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55–68</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hak AE, Pols HA, Visser TJ et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000; 132: 270–278</mixed-citation><mixed-citation xml:lang="en">Hak AE, Pols HA, Visser TJ et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000; 132: 270–278</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Faber J, Heaf J, Kirkegaard C et al. Simultaneous turnover studies of thyroxine, 3,5,3’ and 3,3’,5’-triiodothyronine, 3,5-, 3,3’-, and 3’,5’- diiodothyronine, and 3’-monoiodothyronine in chronic renal failure. J Clin Endocrinol Metab 1983; 56: 211–217. Doi: 10.1210/jcem-56-2-211</mixed-citation><mixed-citation xml:lang="en">Faber J, Heaf J, Kirkegaard C et al. Simultaneous turnover studies of thyroxine, 3,5,3’ and 3,3’,5’-triiodothyronine, 3,5-, 3,3’-, and 3’,5’- diiodothyronine, and 3’-monoiodothyronine in chronic renal failure. J Clin Endocrinol Metab 1983; 56: 211–217. Doi: 10.1210/jcem-56-2-211</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kaptein EM, Quion-Verde H, Chooljian CJ et al. The thyroid in end-stage renal disease. Medicine (Baltimore) 1988; 67: 187–197</mixed-citation><mixed-citation xml:lang="en">Kaptein EM, Quion-Verde H, Chooljian CJ et al. The thyroid in end-stage renal disease. Medicine (Baltimore) 1988; 67: 187–197</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
